The Incremental Benefits of the Predictive Low-Glucose Suspend Function Compared to the Low-Glucose Suspend Function as Automation Against Hypoglycemia in Sensor-Augmented Pump Therapy

J Diabetes Sci Technol. 2018 Nov;12(6):1241-1243. doi: 10.1177/1932296818791536. Epub 2018 Jul 30.
No abstract available

Keywords: continuous glucose monitoring; low-glucose suspend function; predictive low-glucose suspend function; sensor-augmented pump therapy; type 1 diabetes.

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Automation* / instrumentation
  • Automation* / methods
  • Biosensing Techniques* / instrumentation
  • Biosensing Techniques* / methods
  • Blood Glucose / analysis*
  • Blood Glucose / metabolism
  • Blood Glucose Self-Monitoring / instrumentation
  • Blood Glucose Self-Monitoring / methods
  • Diabetes Mellitus, Type 1* / blood
  • Diabetes Mellitus, Type 1* / drug therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Hypoglycemia / blood
  • Hypoglycemia / chemically induced
  • Hypoglycemia / diagnosis
  • Hypoglycemia / prevention & control*
  • Insulin / administration & dosage*
  • Insulin / adverse effects
  • Insulin Infusion Systems*
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prognosis
  • Young Adult

Substances

  • Blood Glucose
  • Insulin